TY - JOUR
KW - Analgesics, Opioid/adverse effects
KW - Animals
KW - Case-Control Studies
KW - Cross-Sectional Studies
KW - Heroin
KW - Humans
KW - interindividual variation
KW - Methadone
KW - Methadone/pharmacology/therapeutic use
KW - MMT
KW - Opioid-Related Disorders/drug therapy/genetics
KW - opioid-related use disorders
KW - OPRM1
KW - Polymorphism, Single Nucleotide/genetics
KW - Receptors, Opioid, mu/genetics
KW - SNP
KW - Systematic Review
AU - B. Oueslati
AU - O. Moula
AU - R. Ghachem
A1 - 
BT - Pharmacogenomics
C5 - Opioids & Substance Use
CP - 8
CY - England
DO - 10.2217/pgs-2018-0017
IS - 8
JF - Pharmacogenomics
PP - England
PY - 2018
SN - 1744-8042; 1462-2416
SP - 741
EP - 747
EP - 
T1 - The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review
T2 - Pharmacogenomics
TI - The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review
U1 - Opioids & Substance Use
U2 - 29785888
U3 - 10.2217/pgs-2018-0017
VL - 19
VO - 1744-8042; 1462-2416
Y1 - 2018
ER -